Table 1.
Human Study Subject Characteristics (Gene Expression Experiments).
| Subjects | Control | Obese pre-surgery | Obese post-surgery |
|---|---|---|---|
| N = 3 | N = 10 | N = 10 | |
| Weight (kg) | 64.13 (± 8.12) | 124.95 (± 13.33) | 103.48 (+ 12.19) |
| Height (cm) | 161.76 (± 7.35) | 166.85 (+ 6.34) | 166.53 (+ 6.50) |
| BMI (kg/m^2) | 24.53 (± 2.59) | 44.95 (+ 5.12) | 37.41 (+ 4.86) |
| Age | 39 (± 16.52) | 36 (+ 8.96) | 36.2 (+ 8.66) |
| HbA1c (%) at Screening | 5.43 (± 0.30) | 5.54 (± 0.36) | 5.54 (± 0.36) |
| Fasting Glucose (mg/dL) | 87.55 (± 21.61) | 87.38 (± 5.11) | 75.55 (± 6.23) |
| Fasting Insulin (pmol/L) | 56.52 (± 9.57) | 121.57 (± 78.65) | 29.37 (± 16.12) |
IVGTTs were not performed or could not be safely completed for some subjects in the study. For obese pre-surgery, fasting glucose and insulin is shown for 7/10 subjects, and for obese post-surgery it is shown to 6/10 subjects.